Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Insider buying?
View:
Post by riverrrow on Nov 10, 2023 10:12am

Insider buying?

I wouldn't be surprised to see insiders buy 1 million units.  GLTA.
Comment by reconsider on Nov 10, 2023 10:17am
That wouldn't be much skin in the game. Can someone explain why our Chief Scientific Officer owns less shares than most people in this board?
Comment by DJDawg on Nov 10, 2023 10:25am
I don't know the exact details but I believe he has large amount of options as part of remuneration package. He has bought more over the years and never sold.
Comment by Legit62 on Nov 10, 2023 10:32am
You would think that if Roger wants more shares and knows this will take off now is the time to grab, even though i believe he has over 14 million shares
Comment by BudFoxx2020 on Nov 10, 2023 10:50am
A lot of new investors really don't undestand how managment holdings works.  Managment gets 99% of their shares for free, not just TLT it applies to any other company out there.  On top of that they get their salaries and bonuses.  Like I said the top 3 management in TLT clears almost $700k a year in salaries.  Unlike management, shareholders cough up the real dollars out ...more  
Comment by StevenBirch on Nov 10, 2023 10:58am
I'm just glad November has 30 days and not 31, one less day to have to suffer while we wait for an update. An update that Dr. Mandel said TLT is looking forward to sharing with us. Closing the financing would help a little but as always the only thing that will really help is positive BTD news. The data has always been positive.
Comment by Alamir1111 on Nov 10, 2023 12:28pm
I think there is a rule for insiders to purchase stocks when material news are expected.there is a certain time line before  they allowed to purchase otherwise it would be classified as conflict of intetest
Comment by Alamir1111 on Nov 10, 2023 12:47pm
If we all knew what's going to happen tomorrow regarding stock market we all be billioners. And remember if you lose 100 bucks somebody else gains 100
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250